BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Mariam Jamal-Hanjani speaks to ecancer at ESMO 2018 about the PEACE (Posthumous Evaluation of Advanced Cancer Environment) study which looks at metastatic tissue samples from recently deceased patients.
She outlines some of the genetic patterns emerging from early data, and what this might suggest for drivers of metastatic progression and treatment.
Dr Jamal-Hanjani also outlines the work on an individual patient level, by analysing their treatment history and observing the status of the tumour post death.
She finalises by exploring further the idea of biobanking and the potential vault of data that could be exploited through this method.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
The added value of integrative medicine
Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology